Clinical Trials Browser

Phase 2 × Recurrence × lobaplatin × Clear all

NCT03613753 2020-02-05

Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer

Phase 2 Unknown

Recurrence, Small Cell Lung Carcinoma